Professor Dr. Kulwant Pawar brings exceptional academic credentials and operational expertise to the Board of Directors at DASHA Pharmaceuticals. With an impressive educational foundation including a BSc (CNAA), MSc (Aston), Membership of the Chartered Management Institute (MCMI), PhD (Aston), and Fellowship of the Chartered Institute of Logistics and Transport (FCILT) from the Academy of Social Sciences of China, Dr. Pawar represents the pinnacle of scholarly achievement in his field. As the distinguished Chair in Operations Management at the University of Nottingham, he has established himself as a leading authority on pharmaceutical operational excellence. Dr. Pawar’s prolific academic contributions include authoring over 300 papers, cementing his status as a thought leader in the industry. His specialized research interests in collaboration within New Product Development teams and management of pharmaceutical R&D supply chains provide DASHA Pharmaceuticals with invaluable insights at the critical intersection of innovation, efficiency, and market delivery—expertise that strengthens the company’s competitive position in developing and bringing life-changing medications to patients worldwide.